MIBio 2018 Programme - click titles for abstracts

08:00 Registration opens

09:00 Opening remarks

Morning session:

09:15  The Past, Present and One Possible Future for Biopharmaceutical Therapies
Ian Tomlinson
Chairman, Stevenage Bioscience Catalyst, formerly co-founder of Domantis and Senior VP at GSK Biopharm

09:45 Robustness Studies During Biopharmaceutical Formulation Development
Tanvir Tabish
Head of Formulation Development, Shire, Austria

10:15 Speed Networking

11:15 Novel Molecules Require Novel thinking! Formulation & Analytical Challenges
Adrian Podmore
Scientist II in the department Dosage Form, Delivery and Devices (DFDD), MedImmune, UK

11:45 Regulation of Drug Device Combination Products within the EU
April Kent
Regulatory Affairs Manager, Amgen, UK

12:15 Lunch Break, Exhibition and Posters

13:30 Introduction to the afternoon session

13:45 Discussion panel

14:45 Exhibitors highlights

15:30 Coffee break, Exhibition and Posters

16:00 Characterisation and Formulation of Virus Therapeutics
Andrea Hawe
Chief Scientific Officer, Coriolis, Germany

16:30 Title to be announced
Sahar Awwad
School of Pharmacy, University College London, UK

17:00 Concluding remarks

17:10 Conference ends

 

Register Now